Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Royal College of General Practioners - Birmingham Research Unit: Annual prevalence report. 2006, Accessed at
http://www.rcgp.org.uk/pdf/Annual%20prevalence%20report%202006.pdf
on January 25, 2012
2. Nuesch E, Dieppe P, Reichenbach S, Williams S, Iff S, Juni P: All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ. 2011, 342: d1165-10.1136/bmj.d1165.
3. Kivitz AJ, Moskowitz RW, Woods E, Hubbard RC, Verburg KM, Lefkowith JB, Geis GS: Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip. J Int Med Res. 2001, 29: 467-479.
4. McKenna F, Borenstein D, Wendt H, Wallemark C, Lefkowith JB, Geis GS: Celecoxib versus diclofenac in the management of osteoarthritis of the knee. Scand J Rheumatol. 2001, 30: 11-18. 10.1080/030097401750065265.
5. Zhao SZ, McMillen JI, Markenson JA, Dedhiya SD, Zhao WW, Osterhaus JT, Yu SS: Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib. Pharmacotherapy. 1999, 19: 1269-1278. 10.1592/phco.19.16.1269.30879.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献